Onyx Biotec Limited (NSE:ONYX)

Onyx Biotec Statistics

Total Valuation

Onyx Biotec has a market cap or net worth of INR 580.23 million. The enterprise value is 665.62 million.

Market Cap	580.23M
Enterprise Value	665.62M

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Onyx Biotec has 18.13 million shares outstanding. The number of shares has increased by 29.63% in one year.

Current Share Class	18.13M
Shares Outstanding	18.13M
Shares Change (YoY)	+29.63%
Shares Change (QoQ)	+8.27%
Owned by Insiders (%)	65.89%
Owned by Institutions (%)	n/a
Float	5.91M

Valuation Ratios

The trailing PE ratio is 49.39.

PE Ratio	49.39
Forward PE	n/a
PS Ratio	0.87
PB Ratio	1.06
P/TBV Ratio	1.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.88, with an EV/FCF ratio of -13.36.

EV / Earnings	62.32
EV / Sales	1.00
EV / EBITDA	11.88
EV / EBIT	26.32
EV / FCF	-13.36

Financial Position

The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.29.

Current Ratio	1.77
Quick Ratio	1.17
Debt / Equity	0.29
Debt / EBITDA	2.81
Debt / FCF	-3.16
Interest Coverage	2.14

Financial Efficiency

Return on equity (ROE) is 2.57% and return on invested capital (ROIC) is 2.44%.

Return on Equity (ROE)	2.57%
Return on Assets (ROA)	1.86%
Return on Invested Capital (ROIC)	2.44%
Return on Capital Employed (ROCE)	4.00%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.86M
Profits Per Employee	29,919
Employee Count	357
Asset Turnover	0.78
Inventory Turnover	3.99

Taxes

In the past 12 months, Onyx Biotec has paid 6.79 million in taxes.

Income Tax	6.79M
Effective Tax Rate	38.87%

Stock Price Statistics

The stock price has decreased by -59.08% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-59.08%
50-Day Moving Average	36.55
200-Day Moving Average	46.86
Relative Strength Index (RSI)	39.61
Average Volume (20 Days)	16,600

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Onyx Biotec had revenue of INR 663.87 million and earned 10.68 million in profits. Earnings per share was 0.65.

Revenue	663.87M
Gross Profit	187.63M
Operating Income	25.29M
Pretax Income	17.47M
Net Income	10.68M
EBITDA	56.03M
EBIT	25.29M
Earnings Per Share (EPS)	0.65

Balance Sheet

The company has 71.89 million in cash and 157.28 million in debt, with a net cash position of -85.39 million or -4.71 per share.

Cash & Cash Equivalents	71.89M
Total Debt	157.28M
Net Cash	-85.39M
Net Cash Per Share	-4.71
Equity (Book Value)	547.22M
Book Value Per Share	30.38
Working Capital	223.05M

Cash Flow

In the last 12 months, operating cash flow was -37.97 million and capital expenditures -11.84 million, giving a free cash flow of -49.81 million.

Operating Cash Flow	-37.97M
Capital Expenditures	-11.84M
Free Cash Flow	-49.81M
FCF Per Share	-2.75

Margins

Gross margin is 28.26%, with operating and profit margins of 3.81% and 1.61%.

Gross Margin	28.26%
Operating Margin	3.81%
Pretax Margin	2.63%
Profit Margin	1.61%
EBITDA Margin	8.44%
EBIT Margin	3.81%
FCF Margin	n/a

Dividends & Yields

Onyx Biotec does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.63%
Shareholder Yield	-29.63%
Earnings Yield	1.84%
FCF Yield	-8.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4